Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients

Chagas disease cardiomyopathy (CCC) is an inflammatory dilated cardiomyopathy occurring in 30% of the 6 million infected with the protozoan Trypanosoma cruzi in Latin America. Survival is significantly lower in CCC than ischemic (IC) and idiopathic dilated cardiomyopathy (DCM). Previous studies disc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Priscila Camillo Teixeira, Axel Ducret, Hanno Langen, Everson Nogoceke, Ronaldo Honorato Barros Santos, João Paulo Silva Nunes, Luiz Benvenuti, Debora Levy, Sergio Paulo Bydlowski, Edimar Alcides Bocchi, Andréia Kuramoto Takara, Alfredo Inácio Fiorelli, Noedir Antonio Stolf, Pablo Pomeranzeff, Christophe Chevillard, Jorge Kalil, Edecio Cunha-Neto
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/74efc1f6125a4af58ae748ca55772c67
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:74efc1f6125a4af58ae748ca55772c67
record_format dspace
spelling oai:doaj.org-article:74efc1f6125a4af58ae748ca55772c672021-11-12T12:11:21ZImpairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients1664-322410.3389/fimmu.2021.755782https://doaj.org/article/74efc1f6125a4af58ae748ca55772c672021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.755782/fullhttps://doaj.org/toc/1664-3224Chagas disease cardiomyopathy (CCC) is an inflammatory dilated cardiomyopathy occurring in 30% of the 6 million infected with the protozoan Trypanosoma cruzi in Latin America. Survival is significantly lower in CCC than ischemic (IC) and idiopathic dilated cardiomyopathy (DCM). Previous studies disclosed a selective decrease in mitochondrial ATP synthase alpha expression and creatine kinase activity in CCC myocardium as compared to IDC and IC, as well as decreased in vivo myocardial ATP production. Aiming to identify additional constraints in energy metabolism specific to CCC, we performed a proteomic study in myocardial tissue samples from CCC, IC and DCM obtained at transplantation, in comparison with control myocardial tissue samples from organ donors. Left ventricle free wall myocardial samples were subject to two-dimensional electrophoresis with fluorescent labeling (2D-DIGE) and protein identification by mass spectrometry. We found altered expression of proteins related to mitochondrial energy metabolism, cardiac remodeling, and oxidative stress in the 3 patient groups. Pathways analysis of proteins differentially expressed in CCC disclosed mitochondrial dysfunction, fatty acid metabolism and transmembrane potential of mitochondria. CCC patients’ myocardium displayed reduced expression of 22 mitochondrial proteins belonging to energy metabolism pathways, as compared to 17 in DCM and 3 in IC. Significantly, 6 beta-oxidation enzymes were reduced in CCC, while only 2 of them were down-regulated in DCM and 1 in IC. We also observed that the cytokine IFN-gamma, previously described with increased levels in CCC, reduces mitochondrial membrane potential in cardiomyocytes. Results suggest a major reduction of mitochondrial energy metabolism and mitochondrial dysfunction in CCC myocardium which may be in part linked to IFN-gamma. This may partially explain the worse prognosis of CCC as compared to DCM or IC.Priscila Camillo TeixeiraPriscila Camillo TeixeiraAxel DucretHanno LangenEverson NogocekeRonaldo Honorato Barros SantosJoão Paulo Silva NunesJoão Paulo Silva NunesJoão Paulo Silva NunesJoão Paulo Silva NunesLuiz BenvenutiDebora LevySergio Paulo BydlowskiEdimar Alcides BocchiAndréia Kuramoto TakaraAlfredo Inácio FiorelliNoedir Antonio StolfPablo PomeranzeffChristophe ChevillardJorge KalilJorge KalilJorge KalilEdecio Cunha-NetoEdecio Cunha-NetoEdecio Cunha-NetoFrontiers Media S.A.articlechronic Chagas disease cardiomyopathyischemic cardiomyopathyidiopathic dilated cardiomyopathyproteomicstwo-dimensional electrophoresis with fluorescent labelingmitochondriaImmunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic chronic Chagas disease cardiomyopathy
ischemic cardiomyopathy
idiopathic dilated cardiomyopathy
proteomics
two-dimensional electrophoresis with fluorescent labeling
mitochondria
Immunologic diseases. Allergy
RC581-607
spellingShingle chronic Chagas disease cardiomyopathy
ischemic cardiomyopathy
idiopathic dilated cardiomyopathy
proteomics
two-dimensional electrophoresis with fluorescent labeling
mitochondria
Immunologic diseases. Allergy
RC581-607
Priscila Camillo Teixeira
Priscila Camillo Teixeira
Axel Ducret
Hanno Langen
Everson Nogoceke
Ronaldo Honorato Barros Santos
João Paulo Silva Nunes
João Paulo Silva Nunes
João Paulo Silva Nunes
João Paulo Silva Nunes
Luiz Benvenuti
Debora Levy
Sergio Paulo Bydlowski
Edimar Alcides Bocchi
Andréia Kuramoto Takara
Alfredo Inácio Fiorelli
Noedir Antonio Stolf
Pablo Pomeranzeff
Christophe Chevillard
Jorge Kalil
Jorge Kalil
Jorge Kalil
Edecio Cunha-Neto
Edecio Cunha-Neto
Edecio Cunha-Neto
Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients
description Chagas disease cardiomyopathy (CCC) is an inflammatory dilated cardiomyopathy occurring in 30% of the 6 million infected with the protozoan Trypanosoma cruzi in Latin America. Survival is significantly lower in CCC than ischemic (IC) and idiopathic dilated cardiomyopathy (DCM). Previous studies disclosed a selective decrease in mitochondrial ATP synthase alpha expression and creatine kinase activity in CCC myocardium as compared to IDC and IC, as well as decreased in vivo myocardial ATP production. Aiming to identify additional constraints in energy metabolism specific to CCC, we performed a proteomic study in myocardial tissue samples from CCC, IC and DCM obtained at transplantation, in comparison with control myocardial tissue samples from organ donors. Left ventricle free wall myocardial samples were subject to two-dimensional electrophoresis with fluorescent labeling (2D-DIGE) and protein identification by mass spectrometry. We found altered expression of proteins related to mitochondrial energy metabolism, cardiac remodeling, and oxidative stress in the 3 patient groups. Pathways analysis of proteins differentially expressed in CCC disclosed mitochondrial dysfunction, fatty acid metabolism and transmembrane potential of mitochondria. CCC patients’ myocardium displayed reduced expression of 22 mitochondrial proteins belonging to energy metabolism pathways, as compared to 17 in DCM and 3 in IC. Significantly, 6 beta-oxidation enzymes were reduced in CCC, while only 2 of them were down-regulated in DCM and 1 in IC. We also observed that the cytokine IFN-gamma, previously described with increased levels in CCC, reduces mitochondrial membrane potential in cardiomyocytes. Results suggest a major reduction of mitochondrial energy metabolism and mitochondrial dysfunction in CCC myocardium which may be in part linked to IFN-gamma. This may partially explain the worse prognosis of CCC as compared to DCM or IC.
format article
author Priscila Camillo Teixeira
Priscila Camillo Teixeira
Axel Ducret
Hanno Langen
Everson Nogoceke
Ronaldo Honorato Barros Santos
João Paulo Silva Nunes
João Paulo Silva Nunes
João Paulo Silva Nunes
João Paulo Silva Nunes
Luiz Benvenuti
Debora Levy
Sergio Paulo Bydlowski
Edimar Alcides Bocchi
Andréia Kuramoto Takara
Alfredo Inácio Fiorelli
Noedir Antonio Stolf
Pablo Pomeranzeff
Christophe Chevillard
Jorge Kalil
Jorge Kalil
Jorge Kalil
Edecio Cunha-Neto
Edecio Cunha-Neto
Edecio Cunha-Neto
author_facet Priscila Camillo Teixeira
Priscila Camillo Teixeira
Axel Ducret
Hanno Langen
Everson Nogoceke
Ronaldo Honorato Barros Santos
João Paulo Silva Nunes
João Paulo Silva Nunes
João Paulo Silva Nunes
João Paulo Silva Nunes
Luiz Benvenuti
Debora Levy
Sergio Paulo Bydlowski
Edimar Alcides Bocchi
Andréia Kuramoto Takara
Alfredo Inácio Fiorelli
Noedir Antonio Stolf
Pablo Pomeranzeff
Christophe Chevillard
Jorge Kalil
Jorge Kalil
Jorge Kalil
Edecio Cunha-Neto
Edecio Cunha-Neto
Edecio Cunha-Neto
author_sort Priscila Camillo Teixeira
title Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients
title_short Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients
title_full Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients
title_fullStr Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients
title_full_unstemmed Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients
title_sort impairment of multiple mitochondrial energy metabolism pathways in the heart of chagas disease cardiomyopathy patients
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/74efc1f6125a4af58ae748ca55772c67
work_keys_str_mv AT priscilacamilloteixeira impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT priscilacamilloteixeira impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT axelducret impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT hannolangen impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT eversonnogoceke impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT ronaldohonoratobarrossantos impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT joaopaulosilvanunes impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT joaopaulosilvanunes impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT joaopaulosilvanunes impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT joaopaulosilvanunes impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT luizbenvenuti impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT deboralevy impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT sergiopaulobydlowski impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT edimaralcidesbocchi impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT andreiakuramototakara impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT alfredoinaciofiorelli impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT noedirantoniostolf impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT pablopomeranzeff impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT christophechevillard impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT jorgekalil impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT jorgekalil impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT jorgekalil impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT edeciocunhaneto impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT edeciocunhaneto impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT edeciocunhaneto impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
_version_ 1718430559170985984